Marijuana Schedule III: 4 Things Federal Employees Must Know

Last Updated: April 29, 2026 Reading Time: 9 min

The Department of Justice issued an order on April 22, 2026 moving two narrow categories of marijuana to Schedule III, and the federal-employee internet promptly lost the plot. Reddit threads lit up with claims that drug tests were going away, that medical marijuana was now safe for clearance holders, that off-duty use in legal states was suddenly fine. None of that is true. The order changed less than people think, and for federal employees the practical answer to almost every question is the same as it was a week ago. Here is what actually happened, and what to do about it.

Key Takeaways

• The April 22, 2026 DOJ order moved only two narrow categories to Schedule III: FDA-approved marijuana products (mainly Epidiolex) and state-licensed medical marijuana. Recreational marijuana remains Schedule I.
• HHS confirmed in March 2026 that federal drug testing panels are unchanged. Marijuana stays on the panel.
• Adjudicative Guideline H, SEAD-4, and ODNI 2021 guidance are all unchanged. Security clearances are still at risk for new use.
• A broader DEA hearing on full rescheduling begins June 29, 2026, with no final rule expected before late 2026 at earliest.

What the Order Actually Did

Acting Attorney General Todd Blanche signed the order on April 22, 2026 under Section 811(d)(1) of the Controlled Substances Act, a treaty-compliance authority that bypasses the normal notice-and-comment process. Three Federal Register documents followed on April 28: a final rule on FDA-approved products (2026-08176), a notice of hearing for broader rescheduling (2026-08177), and a withdrawal of an earlier 2024 proceeding (2026-08178).

Two specific categories moved to Schedule III, immediately:

1. FDA-approved marijuana drug products. Today, this is essentially Epidiolex, a cannabidiol product approved for rare seizure disorders. The order also covers any future FDA-approved marijuana drug.
2. State-licensed medical marijuana. Marijuana subject to a qualifying state-issued medical marijuana license is reclassified.

The order's own language is explicit about what did not change: "any form of marijuana other than in an FDA-approved drug product or marijuana subject to a state medical marijuana license remains a schedule I controlled substance." Recreational marijuana, possessed without a state medical license or FDA-approved prescription, is still Schedule I federally. That is the form of marijuana most people are asking about.

A broader DEA administrative hearing on whether to reschedule all marijuana runs from June 29 through July 15, 2026 at 700 Army Navy Drive in Arlington, Virginia. The deadline for parties to notify DEA of intent to participate is May 28, 2026. Even if that hearing leads to a recommendation to reschedule, a final rule would not take effect for months and would face near-certain litigation.

Question 1: Can I Use Marijuana Now?

No. Not for federal employees, under any currently operative policy.

Executive Order 12564, signed by President Reagan in 1986, requires federal employees to refrain from illegal drug use on- or off-duty. The order has never been revoked. Its operative phrase is straightforward: "the use of illegal drugs by Federal employees, whether on duty or off duty, is contrary to the efficiency of the service." There is no carve-out for personal time at home in a state where marijuana is legal.

State law does not help. Thirty-nine states and DC have legalized some form of marijuana, and none of that matters to federal employment. Federal law preempts state law on the question of whether you can be removed for drug use. The Forest Service has told its employees in writing that they "must remain drug-free and refrain from federally prohibited drug use whether on- or off-duty, regardless of state law." Every other federal agency takes the same position.

Medical marijuana cards offer zero protection. There is no federally valid marijuana prescription that a doctor can write today. Epidiolex is the only currently FDA-approved cannabis-derived medication, and it is prescribed for specific seizure disorders, not anxiety, pain, or general wellness. A state-issued medical card is not a federal prescription. Tully Rinckey's analysis is direct: "State-legal medical marijuana is not federally legal medical marijuana."

The April 22 order does not create permission to use. It reclassifies two narrow categories and leaves the federal-employee prohibition intact.

Question 2: Will My Agency Still Drug Test for Marijuana?

Yes. Every federal agency that currently tests for marijuana will continue to test for marijuana.

Federal drug testing operates on three legal layers:

1. Executive Order 12564 authorizes federal drug-free workplace programs.
2. HHS Mandatory Guidelines set the technical standards (which drugs are tested, what cutoffs, which labs).
3. Agency Drug-Free Workplace Plans define which positions are tested (Testing Designated Positions, or TDPs) and consequences.

HHS made its position explicit in a Federal Register notice on March 13, 2026: "no revisions to the current drug testing panels for both urine and oral fluid" and "the current authorized drug testing panels and required report nomenclature remain in effect." DOT issued a parallel notice on December 19, 2025 covering its 49 CFR Part 40 testing program for safety-sensitive workers. Marijuana stays on the panel.

Federal Drug Testing by Agency Category

Agency / Employee Category	Tests for Marijuana?	Consequence of Positive	What Schedule III Order Changed
DoD civilian (TDP)	Yes (full panel)	Removal, clearance action	Nothing today
Cleared civilian (TS / SCI)	Yes (full panel)	Clearance revocation + removal	Nothing; Guideline H unchanged
Uncleared GS, non-TDP	Not routinely; reasonable suspicion only	Removal if positive	Nothing; EO 12564 still applies
TSA, DOT safety-sensitive	Yes (49 CFR Part 40)	Removal, FMCSA Clearinghouse entry	Nothing today
USPS	Yes	Removal; pre-employment positive bars hire	Nothing today
VA healthcare workers	Yes	Removal; medical card = ineligibility for VA employment	Nothing
Active-duty military	Yes (urinalysis)	UCMJ action, discharge	Separate framework, no change

If you hold a non-TDP uncleared GS position at a non-DoD agency and are not subject to random testing, the legal prohibition under EO 12564 still applies. Reasonable suspicion testing can occur at any time, and any agency can add positions to its TDP list at any time.

The Longer-Term HHS Authority Question

There is a future legal issue worth understanding even though it changes nothing today. The HHS Mandatory Guidelines are written to authorize testing for Schedule I and Schedule II substances. If marijuana eventually moves fully to Schedule III, HHS would technically lose authority under the current guidelines to mandate marijuana testing. Industry groups, including the National Drug and Alcohol Screening Association, are already pushing Congress for a statutory fix to preserve testing authority before any broader rescheduling takes effect. As long as recreational marijuana remains Schedule I, there is no real gap. If broader rescheduling moves forward, expect Congress to act before testing authority lapses, and expect agencies to lean on EO 12564 even if HHS-mandated testing has to be revised.

Question 3: Does Marijuana Use Affect My Security Clearance?

Yes, and the April 2026 order does not change that at all.

Security clearance eligibility is governed by:

• Adjudicative Guideline H, Drug Involvement (32 CFR Part 147), the primary standard for evaluating drug-related conduct.
• Adjudicative Guideline E, Personal Conduct, which covers honesty and disregard for rules.
• SEAD-4 (Security Executive Agent Directive 4), the policy framework for the clearance process.
• ODNI's December 21, 2021 Clarifying Guidance, the controlling adjudicative framework specifically for marijuana.

ClearanceJobs published a direct analysis on April 26, 2026: reclassification "does not create a green light for clearance holders to use marijuana." Past use was illegal at the time it occurred, and reclassification is not retroactive. Future use will be evaluated at your next reinvestigation under the standards in effect at that time, which today are unchanged.

What Adjudicators Actually Consider Under Guideline H

The "whole person" concept governs. Factors include:

• Recency. Use within 12 months raises significant concerns. Use within months of an application makes approval very difficult.
• Frequency. Habitual or regular use is treated more seriously than experimentation.
• Intent to continue. Any stated or implied intent to continue using is close to a guaranteed denial.
• Context. On-duty vs. off-duty, before or during federal employment, before or during clearance.
• Candor. Honest disclosure beats omission. Concealment that is later discovered creates a separate Guideline E violation.
• Rehabilitation. Demonstrated abstinence and stable rehabilitation help.

The PVQ "90-Day Trap"

The SF-86 is being replaced by the Personnel Vetting Questionnaire (PVQ), approved by OMB in December 2023 and rolling out across government. The PVQ separates cannabis questions from other illegal-drug questions and uses a 90-day threshold question for cannabis use. If you answer yes to use within 90 days, you are then asked about all use within the last 5 years.

This is where applicants get into trouble. The 90-day threshold is just the trigger question. It does not reduce the legal disclosure standard. The Bond Amendment defines "current use" as use within one year for purposes of employment disqualification, and polygraph examiners and investigators may still probe beyond what the form asks. Many applicants read the 90-day question and assume they only need to disclose recent use. That is not what the form means, and that misreading has cost applicants their clearances.

The PVQ also does not ask whether your state allowed the use. The question is whether the conduct was illegal. Under federal law, all recreational marijuana use is and has been illegal.

Reciprocity and Investigations

Clearance records follow you between agencies. When you transfer, the gaining agency reviews prior investigations and can either accept the prior adjudication, request additional information, or initiate a new investigation. There is no clean-slate reset. Reinvestigations typically occur every five to ten years depending on level, and any new use discovered will be evaluated under the Guideline H standards at the time of discovery.

The FBI separately reduced its automatic-disqualification window from three years to twelve months for past marijuana use. That is FBI-specific. Outside the FBI, the standard is the whole-person Guideline H analysis.

Question 4: What Should Federal Employees Actually Do?

The short version: do not use, and disclose honestly if asked.

Practical Risk by Employee Category

Employee Category	Risk of Use Today	Recommended Action
Active clearance holder (any level)	Career-ending	Do not use. Disclose honestly on PVQ/SF-86.
Cleared employee facing reinvestigation or polygraph	Career-ending	Do not use. Review past disclosure with a clearance attorney before submitting.
Uncleared GS, TDP position	High; positive test = removal	Do not use.
Uncleared GS, non-TDP	Lower test risk, but still terminable under EO 12564	Wait for agency-specific guidance before treating any change as permission.
Federal job applicant (no clearance)	OPM suitability evaluated case by case	Past use evaluated on nexus standard. Recent use is riskier.
Federal contractor with clearance	Same as cleared fed	Same as cleared fed.
USPS, TSA, DOT safety-sensitive	High; DOT Part 40 testing applies	Do not use.

Wait for Agency-Specific Guidance

No major federal agency has issued revised marijuana guidance since April 22. The DEA hearing is administrative, not a policy change. A final broader rescheduling rule, if it ever comes, will be followed by HHS guideline amendments, agency-by-agency policy review, and potentially congressional action. Each step takes months. Treating the April 22 order as permission to use is a misread that carries career-ending consequences.

Disclose Honestly

The general rule in clearance law is that honest disclosure beats omission. If the PVQ or SF-86 asks about cannabis use, answer truthfully. Past use disclosed honestly with demonstrated rehabilitation is frequently survivable under Guideline H. Concealment that is later discovered, especially via polygraph or a follow-up interview, creates a separate Guideline E violation that is often more disqualifying than the underlying conduct.

For employees with prior use who are not currently being investigated, there is generally no duty to proactively self-report past use you were never asked about and never disclosed. Any new investigation will revisit it.

CBD Products: A Separate Warning

Hemp-derived CBD (under 0.3% THC) is federally legal, but the supplement market is unregulated, and mislabeled products with higher-than-labeled THC can accumulate and trigger a positive drug test. Delta-8 THC, THCO, and other hemp-derived cannabinoids are a gray area with similar risk. The Forest Service has explicitly warned employees about this. Do not assume any cannabis-derived supplement is safe for drug testing.

What Reddit Got Wrong

The r/fednews thread on the order generated more than 1,100 upvotes and 200 comments, and the comment section is a useful catalog of what people think changed but did not. Five misconceptions in particular are worth correcting directly.

What Reddit is saying	What is actually true
"Schedule III means it is legal now and my agency cannot test me."	Scheduling affects regulation and criminal classification, not agency testing authority. HHS confirmed panels are unchanged. EO 12564 prohibits use independent of scheduling.
"I live in a legal state, so I am fine."	Federal employment is governed by federal law. State legality is irrelevant. Federal employees have been removed for off-duty use in legal states.
"Medical marijuana is different. If I have a state card, my employer must accommodate me."	The ADA does not require accommodation for currently illegal drug use under federal law. State medical cards have no standing in federal employment or clearance law.
"The PVQ only asks about 90 days now, so my exposure is shorter."	The 90-day question is a trigger. A "yes" answer requires disclosure of all use in the last 5 years. The Bond Amendment defines current use as within one year for employment purposes. Polygraphs can ask about more.
"My clearance is already approved, so this grandfathers me in."	A current clearance is not a license to start using a previously prohibited substance. New use will be adjudicated at reinvestigation. ClearanceJobs (April 26, 2026) confirmed reclassification does not green-light current holders.

Plan for the Worst Case Before You Need To

If you are weighing your job risk, run two numbers before any new investigation or testing event:

• The free FedTools Severance Pay Calculator estimates the lump sum you would receive if separated by the federal government.
• The FERS Retirement Calculator projects your annuity at different retirement dates if you are weighing whether to retire rather than risk an investigation outcome.

Run your severance numbers →

Frequently Asked Questions

Did the DOJ reschedule all marijuana to Schedule III in April 2026?

No. The April 22, 2026 order moved only two narrow categories to Schedule III: FDA-approved marijuana drug products (primarily Epidiolex for seizure disorders) and state-licensed medical marijuana. Recreational marijuana explicitly remains Schedule I under the order's own language. A broader DEA hearing to evaluate full rescheduling begins June 29, 2026.

Can I be fired for marijuana use as a federal employee even in a legal state?

Yes. Executive Order 12564 (1986) requires federal employees to refrain from illegal drug use on- and off-duty, and federal law preempts state law. Multiple federal employees have been removed for off-duty marijuana use in states where it was legal under state law. The April 2026 order does not change this.

Does Schedule III mean my agency will stop drug testing for marijuana?

Not today. HHS confirmed in a March 13, 2026 Federal Register notice that authorized testing panels are unchanged. Marijuana stays on the panel. There is a longer-term legal question about HHS testing authority if all marijuana eventually moves to Schedule III, but it has not changed anything as of April 29, 2026.

I hold a security clearance. Can I use marijuana now?

No. Adjudicative Guideline H (Drug Involvement), SEAD-4, and the ODNI December 2021 Clarifying Guidance are all unchanged. ClearanceJobs confirmed on April 26, 2026 that reclassification does not create a green light for clearance holders. Any new use is adjudicable conduct at your next reinvestigation or if self-reported.

I used marijuana before I became a federal employee. Does it matter?

It depends on recency, frequency, and whether you are seeking a clearance. OPM's 2021 memo says past marijuana use is not an automatic suitability disqualifier under 5 CFR 731, but it must be assessed case by case. For clearance positions, Guideline H weighs recency (use within 12 months raises significant concerns), frequency, intent to continue, and rehabilitation. Disclose honestly if asked on the SF-86 or PVQ.

Does the order help federal employees with a marijuana prescription?

Not in any practical way today. The only currently FDA-approved marijuana-derived product is Epidiolex (cannabidiol for specific seizure disorders). There is no federally valid marijuana prescription a doctor can write that would shield a federal employee from a positive THC drug test. State medical marijuana cards have no standing in federal employment or clearance law.

I work for USPS, TSA, or VA. Are the rules different for me?

No, in the direction that matters. USPS follows DOT 49 CFR Part 40 elements for safety-sensitive roles, TSA tests under Part 40, and the VA includes marijuana on its standard testing panel and treats medical marijuana use as automatic ineligibility for VA employment. None of these agencies issued revised guidance after the April 22 order.

What happens if I test positive for marijuana?

For Testing Designated Positions, a confirmed positive after Medical Review Officer review typically leads to removal from federal service, clearance revocation if applicable, and entry into the FMCSA Drug and Alcohol Clearinghouse for safety-sensitive workers. Some agencies offer EAP referral for first-time positives in non-safety positions, but ongoing use or a second positive is typically removal.

Are CBD supplements safe for federal employees?

Generally yes for hemp-derived CBD with under 0.3% THC, but the supplement market is unregulated and mislabeled products can trigger a positive THC test. Delta-8 THC, THCO, and similar hemp-derived cannabinoids are gray areas. The Forest Service has explicitly warned employees about this. No federal employee should assume any cannabis-derived supplement is safe for drug testing purposes.

When could broader rescheduling actually take effect?

A DEA hearing on broader rescheduling runs June 29 to July 15, 2026. The earliest a final rule could take effect is late 2026, more likely 2027 after litigation. Even if all marijuana moves to Schedule III, agency drug testing and clearance rules would not automatically follow. Each step requires separate HHS, agency, and ODNI action.

Related Resources

• Comment Deadline May 4: OPM RIF Rule Veterans Call Illegal: Companion deadline-driven post on the OPM RIF seniority rule
• DoD Union Contract Termination Survival Guide: The CBA protections roughly 300,000 DoD civilians lost in April 2026
• State of the Federal Workforce 2026: Headcount, retention, and clearance-eligible positions in the current workforce
• RIF Survival Guide: Step-by-step preparation, retention register basics, severance, CTAP/ICTAP

Sources: DOJ Press Release, April 22, 2026 · Federal Register 2026-08176, FDA-approved products final rule · Federal Register 2026-04981, HHS testing panels notice · ClearanceJobs, April 26, 2026 · ODNI 2021 Clarifying Guidance · eCFR 32 CFR Part 147 (Adjudicative Guidelines) · OPM 2021 Suitability Memo · US Forest Service Marijuana Guidance